missing translation for 'onlineSavingsMsg'
Läs mer

Invitrogen™ Human DACT3 Synthetic Peptide

Code produit. 15328970
missing translation for 'changeView'
missing translation for 'orderingAttributeHoverText'
Kvantitet:
50 μg
missing translation for 'unitSize':
50µg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Code produit. Kvantitet missing translation for 'unitSize'
15328970 50 μg 50µg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 missing translation for 'options'
Les retours ne sont pas autorisés pour ce produit. Afficher la politique du retour.
Code produit. 15328970 missing translation for 'mfr' Invitrogen™ missing translation for 'supplierNo' PEP0750
 Begränsad artikel
Beräknad leverans: 23-11-2026
Ajouter au panier
Ajouter au panier

missing translation for 'validMainframeMsg'

Les retours ne sont pas autorisés pour ce produit. Afficher la politique du retour.

Synthetic Peptide

This peptide corresponds to 17 amino acids near the amino terminus of human Dact3. PEP-0750 can be used as a blocking peptide with polyclonal antibody PA5-20630.

The Wnt signaling cascade is a conserved process in multicellular animals that plays important roles during development and can contribute to cancer and other diseases. Many members of this pathway are also expressed in the postnatal tissues such as brain. One such protein is Dact3, a member of the Dact protein family that was initially identified through binding to Disheveled (Dvl), a cytoplasmic protein essential to Wnt signaling. Dact3 is expressed in the ventral region of maturing somites, limb bud and branchial arch mesenchyme, embryonic CNS, and the adult brain. Recent evidence shows that Dact3 acts as a negative regulator Wnt/beta-catenin signaling that is repressed at the transcriptional level in colorectal cancer and this repression is associated with bivalent histone modifications. This repression can be reversed by pharmacological agents that targets both histone methylation and deacetylation, suggesting that Dact3 may be a potential target for therapeutic treatment of this cancer. At least three isoforms of Dact3 are known to exist.
TRUSTED_SUSTAINABILITY

Spécification

Gen-ID (Entrez) 147906
Art Human
Reningsmetod purified
Tillträdesnummer Q96B18
Vanligt namn DACT3
Koncentration 200 μg/mL
Innehåll och lagring -20°C
Beskrivning Synthetic Peptide
Formatera Liquid
Formulering PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
För användning med (applikation) Blocking Assay, Control
Gene Alias Antagonist of beta-catenin Dapper homolog 3; arginine-rich region 1 protein; dact 3; Dact3; Dapper antagonist of catenin 3; dapper homolog 3; dapper homolog 3, antagonist of beta-catenin (xenopus); dapper, antagonist of beta-catenin, homolog 3; DAPPER3; dishevelled binding antagonist of beta catenin 3; dishevelled-binding antagonist of beta-catenin 3; EG666671; naa-3; RGD1563892; RRR1
Gensymbol DACT3
Frystorkat material No
Konserveringsmedel Sodium azide
Produkttyp Peptide
Kvantitet 50 μg
Regulatorisk status RUO
Förvaringsbuffert PBS
Afficher plus Afficher moins
Nom du produit
Sélectionnez un problème

En cliquant sur Soumettre, vous reconnaissez que vous pouvez être contacté par Fisher Scientific au sujet des informations que vous avez fournies dans ce formulaire. Nous ne partagerons pas vos informations à d'autres fins. Toutes les informations de contact fournies seront également conservées conformément à notre politique de confidentialité. Politique de confidentialité.